Standard Versus Hypofractionated Radiation Therapy for Bladder Cancer: New Insights, but Questions Remain

Int J Radiat Oncol Biol Phys. 2021 Sep 1;111(1):113-116. doi: 10.1016/j.ijrobp.2021.04.048.

Authors

Brian C Baumann¹, Paul Sargos², Jason A Efstathiou³

Affiliations

¹ Department of Radiation Oncology, Washington University in St Louis, St Louis, Missouri; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: [email protected].
² Department of Radiation Oncology, Institut Bergonié, Bordeaux Cedex, France.
³ Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

No abstract available

Publication types

Editorial
Comment

MeSH terms

Carcinoma, Transitional Cell*
Humans
Radiation Dose Hypofractionation
Urinary Bladder Neoplasms* / radiotherapy